MedPath

Pheniramine

Generic Name
Pheniramine
Brand Names
Naphcon A, Opcon-A, Visine-A
Drug Type
Small Molecule
Chemical Formula
C16H20N2
CAS Number
86-21-5
Unique Ingredient Identifier
134FM9ZZ6M

Overview

Pheniramine is a first-generation antihistamine in the alkylamine class, similar to brompheniramine and chlorpheniramine. It is used in some over-the-counter allergy as well as cold & flu products in combination with other drugs. Pheniramine's use as an anti-allergy medication has largely been supplanted by second-generation antihistamines such as cetirizine and loratadine.

Indication

常用于过敏性疾病和感冒等。

Associated Conditions

  • Allergic Conjunctivitis (AC)
  • Allergic Skin Reaction
  • Allergic urticaria
  • Anaphylaxis
  • Angioedema
  • Atopic Dermatitis
  • Burns first degree
  • Common Cold
  • Congestion of the Conjunctivas
  • Drug hypersensitivity reaction
  • Flu caused by Influenza
  • Insect Bites
  • Neurodermatitis
  • Ocular Irritation
  • Red eye
  • Sunburn
  • Urticaria

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor

No clinical trials found

No clinical trials found for this drug

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
NAPHCON-A STERILE OPHTHALMIC SOLUTION
SIN04717P
SOLUTION
3.0 mg/ml
6/13/1990

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
REDISIL EYE DROPS
N/A
N/A
N/A
1/27/2022

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
VISINE ALLERGY eye drops bottle
66073
Medicine
A
9/17/1998
NAPHCON-A eye drops bottle
47652
Medicine
A
1/24/1994

Health Canada Drug Approvals

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
PULMORPHAN
laboratoire riva inc.
00513741
Syrup - Oral
7.5 MG / 5 ML
12/31/1978
ODAN-VERNACON
odan laboratories ltd
00626643
Solution - Ophthalmic
0.5 %
12/31/1986
COLD STIX
laboratoire riva inc.
02377861
Powder For Solution - Oral
20 MG / SACHET
10/10/2013
COLD STIX-EXTRA STRENGTH
pnp pharmaceuticals inc
02368439
Powder For Solution - Oral
20 MG / 4.5 G
N/A
CALDOMINE DH ADULTE
technilab pharma inc.
00550485
Liquid - Oral
12.5 MG / 5 ML
12/31/1981
HOT LEMON RELIEF POWDER EXTRA STRENGTH
02248704
Powder - Oral
20 MG / 22 G
N/A
HOT LEMON RELIEF EXTRA STRENGTH
north pacific rim marketing inc.
02239203
Powder - Oral
20 MG / 22 G
N/A
HOT LEMON REGULAR - PWR
prodemdis enr.
02141833
Powder ,  Package - Oral
20 MG / PCK
4/15/1997
HOT LEMON COLD & SORE THROAT NIGHT
cellchem pharmaceuticals inc.
02502488
Powder - Oral
20 MG / SACHET
N/A
NEOCITRAN EXTRA STRENGTH COLD & SINUS NIGHT - APPLE CINNAMON
haleon canada ulc
02456982
Powder For Solution - Oral
20 MG / SACHET
8/1/2017

CIMA AEMPS Drug Approvals

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.